JILL JOHNSON: Open Payments
NPI 1821507492 · SUMMERSVILLE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 16 payments from 7 companies in 2025. Trend: 2023 $517 · 2024 $299 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $152 |
| ABBVIE INC. | 4 | $79 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
Products named: Qelbree, VRAYLAR, Auvelity, ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, REXULTI.
Industry payments across WV — which companies pay providers there.
